Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
This study is currently recruiting participants.
Study NCT00281502 Information provided by Weill Medical College of Cornell University
First Received: January 20, 2006 Last Updated: April 30, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatic Encephalopathy
Hepatitis C
Liver Cirrhosis
Additional conditions recognized in this trial
Brain Damage, Chronic
Delirium
Encephalitis
Fibrosis
Hepatitis
Neurotoxicity Syndromes
More general conditions related to this trial
Brain Diseases
Brain Diseases, Metabolic
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Confusion
Delirium, Dementia, Amnestic, Cognitive Disorders
Digestive System Diseases
Disorders of Environmental Origin
Flaviviridae Infections
Hepatic Insufficiency
Hepatitis, Viral, Human
Liver Diseases
Liver Failure
Mental Disorders
Metabolic Diseases
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes
Poisoning
RNA Virus Infections
Signs and Symptoms
Virus Diseases
Interventions listed in this trial
Rifaximin (drug)
Additional drug interventions recognized in this trial
Rifaximin
More general drug interventions related to this trial
Anti-Infective Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Weill Medical College of Cornell University
Salix Pharmaceuticals
Back to top of Main Content
